We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000728:SZSEGuoyuan Securities Company Limited Analysis

Data as of 2026-06-14 - not real-time

CN¥6.97

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Guoyuan Securities is trading at CNY 6.97, well below its 20‑day (CNY 7.05), 50‑day (CNY 7.33) and 200‑day (CNY 8.25) moving averages, signaling a bearish technical backdrop. The RSI sits near 44, hinting at a neutral‑to‑slightly‑oversold condition, while the MACD histogram is negative and the MACD line trails its signal, reinforcing downside momentum. Volume is on a decreasing trend despite still exceeding the 10‑day average, and volatility over the past 30 days is elevated at roughly 23 %, suggesting price swings may persist.
Fundamentally, the company’s revenue has contracted by 12.8 % year‑over‑year, yet it maintains robust gross (54 %) and operating (50 %) margins, delivering a healthy profit margin of 38 %. Valuation metrics are attractive: a trailing P/E of 13.2 versus the industry average of 16.8, and a P/B of 0.78, indicating the stock is priced below book value. The dividend yield of 2.58 % with a modest payout ratio of 34 % appears sustainable given solid operating cash flow, though the balance sheet is leveraged (debt‑to‑equity ~267 %). A DCF‑derived fair value of CNY 28.9 and analyst target prices near CNY 10 suggest considerable upside potential, albeit tempered by high leverage and recent earnings decline.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price hovering near the technical support level of CNY 6.66
  • bearish MACD signal and decreasing trading volume
  • valuation upside but high leverage raises downside risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • substantial valuation gap to DCF fair value and analyst targets
  • stable dividend yield with a comfortable payout ratio
  • potential earnings recovery as margins remain strong

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicates significant long‑run upside
  • consistent dividend policy supports total return
  • low beta reduces sensitivity to broader market swings

Key Metrics & Analysis

Financial Health

Revenue Growth-12.80%
Profit Margin38.59%
P/E Ratio13.2
ROE6.12%
ROA1.23%
Debt/Equity267.33
P/B Ratio0.8
Op. Cash FlowCN¥15.2B
Industry P/E16.8

Technical Analysis

TrendBearish
RSI44.0
SupportCN¥6.66
ResistanceCN¥7.66
MA 20CN¥7.05
MA 50CN¥7.33
MA 200CN¥8.25
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥28.88
Target PriceCN¥9.90
Upside/Downside42.04%
GradeUndervalued
TypeValue
Dividend Yield2.58%

Risk Assessment

Beta0.45
Volatility22.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.